High-level Dolutegravir Resistance Selection on Dolutegravir/Lamivudine

被引：1
|
作者：
Llibre, Josep M. [1 ,2 ,4 ]
Jou, Antoni [2 ,4 ]
Puig, Teresa [3 ]
机构：
[1] Univ Hosp Germans Trias, Infect Dis Div, Badalona, Spain
[2] Fight Infect Fdn, Badalona, Spain
[3] Irsi Caixa AIDS Res Inst, Badalona, Spain
[4] Hosp Univ Germans Trias, Infect Dis, Ctra Canyet S-N, Badalona 08916, Spain
来源：
CLINICAL INFECTIOUS DISEASES | 2024年 / 79卷 / 06期
关键词：
PLUS LAMIVUDINE; NAIVE ADULTS;
D O I：
10.1093/cid/ciae125
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1540 / 1541
页数：2
相关论文
共 50 条
  • [21] Clinical experience using dolutegravir plus lamivudine in Glasgow
    Debono, M.
    Ocker, K.
    Shepherd, S.
    Bell, D.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2022, 25 : 123 - 123
  • [22] Real life evidence on dual therapy with dolutegravir and lamivudine
    Iglessias, A. C. C.
    Madruga, J. V. R.
    Tancredi, M. V.
    Ramos, L. R.
    Moraes, C. A.
    da Costa, A. F.
    Mendes, C. V.
    Kalmar, E. M. N.
    Nogui, F. L. N.
    Muller, P. R.
    Leme, S. T. S.
    Gouveia, J. P. S.
    Souza, T. V. G.
    Sasaki, M.
    Fonsi, M.
    Carvalho, D. G.
    da Silva, D. P.
    de Medeiros, M. F. F.
    Rodrigues, C.
    Nogueira, R. S.
    HIV MEDICINE, 2023, 24 : 120 - 120
  • [23] Clobazam/dolutegravir/lamivudine interactionDevelopment of drug resistance leading to virological failure: case report
    Reactions Weekly, 2022, 1912 (1) : 155 - 155
  • [24] Pharmaceutical Care for HIV patients on treatment with Dolutegravir and Lamivudine
    Perales Pascual, Judit
    Navarro Aznarez, Herminia
    Lopez Perez, Ana
    Abad Banuelos, Beatriz
    Pascual Matinez, Oihana
    PHARMACEUTICAL CARE ESPANA, 2023, 25 (02): : 22 - 33
  • [25] Abacavir plus dolutegravir plus lamivudine for the treatment of HIV
    Comi, Laura
    Maggiolo, Franco
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (15) : 2097 - 2106
  • [26] Acute pancreatitis associated with dolutegravir and lamivudine/abacavir administration
    Thompson, Amelia B.
    Wynn, Bridget A.
    Akerele, David O.
    Rostad, Christina A.
    Anderson, Evan J.
    Camacho-gonzalez, Andres F.
    Spearman, Paul
    Chakraborty, Rana
    AIDS, 2015, 29 (03) : 390 - 392
  • [27] Dolutegravir/dolutegravir/lamivudine/tenofovir/rifampicinLiver injury, renal dysfunction and an increase in serum creatinine: 3 case reports
    Reactions Weekly, 2021, 1879 (1) : 143 - 143
  • [28] Efficacy, durability, and tolerability of dolutegravir/lamivudine and dolutegravir/rilpivirine for the treatment of HIV in a real-world setting in Belgium
    Nasreddine, Rakan
    Yombi, Jean Cyr
    Darcis, Gilles
    Florence, Eric
    Allard, Sabine D.
    De Scheerder, Marie-Angelique
    Henrard, Sophie
    Demeester, Remy
    Messiaen, Peter
    Ausselet, Nathalie
    Loeckx, Matthias
    Delforge, Marc
    De Wit, Stephane
    HIV MEDICINE, 2023, 24 (03) : 267 - 278
  • [29] Genetic Barrier to Resistance for Dolutegravir
    Llibre, Josep M.
    Pulido, Federico
    Garcia, Federico
    Garcia Deltoro, Miguel
    Blanco, Jose L.
    Delgado, Rafael
    AIDS REVIEWS, 2015, 17 (01) : 56 - 64
  • [30] Changes in Serum Inflammatory Markers in Antiretroviral Therapy-Naive HIV-Infected Patients Starting Dolutegravir/Lamivudine or Dolutegravir/Lamivudine/Abacavir
    Calza, Leonardo
    Legnani, Giorgio
    Fulgaro, Ciro
    Verucchi, Gabriella
    Bon, Isabella
    Lazzarotto, Tiziana
    Viale, Pierluigi
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2022, 89 (03) : E30 - E32
12345